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Introduction  
 
The introduction of shock wave lithotripsy (SWL) treatment for renal and ureteric calculi in 
1983 rapidly replaced open surgery for smaller stones. Over time the indications and 
techniques have been constantly redefined in pursuit of a better outcome. 
 
With the arrival of minimally invasive surgical procedures like ureterorenoscopy (URS), 
percutaneous nephrolithotomy (PCNL) and retrograde intrarenal surgery (RIRS) the status of 
SWL has become all the more threatened. But, the unique stature of SWL as a practically ‘no 
touch’ approach in the treatment of urolithiasis scores over these minimally invasive 
techniques. It is therefore imperative, that a continuous effort is made to identify novel 
methods that can improve the treatment outcome of SWL. 
 
One such method proposed is to provide diuresis during the shock wave session to enhance 
the fragmentation and clearance. This is a prospective randomized double blinded placebo 
controlled trial that aims to analyse the effect of diuretics on SWL treatment of renal and 
upper ureteric calculi. 
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Review of literature  
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Review of literature 
 
History of SWL 
SWL represents an offshoot of technology from military development. Dents were noticed on 
the wings of Lockheed F-104 fighter planes when they reached twice the speed of sound. 
Dornier – an aircraft business organisation from Germany investigated this and found that the 
supersonic shock waves generated by the falling rain drops caused local erosion as well as 
changes in the surrounding molecular structure. 
 
Following this, a comprehensive research began involving Dornier and the Ludwig 
Maximilians University in Munich leading on to the first human treatment by Chaussy et al in 
1980 using Dornier HM1 lithotriptor. The first Dornier HM3 was installed at the Klinikum 
Großhadern in Munich in 1983, thereafter, leading on to a global spread of lithotripters and a 
radical change in stone management.(1) 
 
Technique of SWL, physics and theories of stone fragmentation and 
clearance 
Essentials of lithotripsy include a shock wave generator, a system to converge the shock 
waves on a target, a stone localization system and a coupling medium. 
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A shock wave is a sonic pulse which consists of a rapid initial rise of peak pressure to about 
50-80 MPa followed by a longer lower amplitude negative pressure of 10 MPa with a short 
life cycle of less than 10 microsecond.(2) 
 
 
Figure 1: A typical pressure pulse at F2 
 
 
Stones fragment as a result of stress induced by the shock wave. Cracks are induced which 
grow and accumulate with repeated shocks, finally leading on to stone disintegration. The 
mechanisms include tear and shear forces, cavitation, spallation, quasi-static squeezing and 
dynamic squeezing.(3) 
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Table 1: Existing theories of stone fragmentation (3) 
Hypothesis  Mechanism  Pre 
requisites 
Action  Comments  
Tear and 
shear forces 
Pressure 
gradients 
resulting from 
impedance 
changes at the 
front and distal 
stone surface 
with pressure 
inversion 
Shock wave 
smaller in space 
extension than 
the stone 
Hammer like 
action resulting 
in crater like 
fragmentation at 
both ends of the 
stone 
Only relevant 
for small focal 
zones 
Spallation  Reflected tensile 
wave at distal 
surface of the 
stone with 
maximum 
tension at the 
distal part of 
stone 
Shock wave 
smaller in space 
extension than 
the stone 
Breaking the 
stone from 
inside 
Only relevant 
for small focal 
zones 
Quasi static 
squeezing 
Pressure 
gradient 
between 
Shock wave is 
broader than 
stone. Shock 
Nut cracker like 
action requiring 
large focal 
Only relevant 
for large focal 
zones 
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circumferential 
and longitudinal 
waves results in 
squeezing of the 
stone 
wave velocity is 
lower in water 
than in stone 
diameters 
Cavitation  Negative 
pressure waves 
induce a 
collapsing 
bubble at the 
stone surface 
Microexplosive 
erosions at the 
proximal and 
distal ends of 
the stone 
More important 
during stone 
comminution. 
Useful for 
improving the 
efficacy of 
shock waves Dynamic 
squeezing 
Shear waves 
initiated at the 
corner of the 
stone are 
reinforced by 
squeezing waves 
along the 
calculus 
Parallel 
travelling of 
longitudinal 
waves. Shock 
wave velocity is 
lower in water 
than in stone 
Nut cracker like 
action in 
combination 
with spalling 
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Figure 2: Tear and shear forces and cavitation(4) 
 
 
 
 
Figure 3: Spalling(3) 
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Figure 4: Quasistatic squeezing(4) 
 
          
            
 
 
 
Presently, four different types of shock wave generators are used which includes 
electrohydraulic, electromagnetic, piezoelectric and electroconductive. The Dornier HM3 
was the prototype first generation electohydraulic lithotripter, the most powerful till date with 
unmatched stone free rates of up to 90% in uncomplicated non lower polar calculi.(1,4) 
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Coupling media for SWL have ranged from an ideal water bath for Dornier HM3 to the 
present day water filled coupling cushions covered with ultrasound jelly. The efficiency of 
shock waves is inversely proportional to the area occupied by air pockets which can be 
minimised by the judicious use of jelly.(1,4) 
 
Successful SWL depends on precise localisation and monitoring of the calculus during 
treatment. The modern day lithotripters have an option of fluoroscopic as well as ultrasound 
guided localisation techniques. Most often, the first line is the fluoroscopy which has it’s 
inherent advantages of familiarity to the urologist, localisation of the ureteric calculi as well 
and the use of contrast agents, if needed.(1) 
 
 
 
 
Indications  
For renal and ureteric calculi are as follows; 
Renal calculi (5) 
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Table 2: Recommended treatment for renal calculi (5) 
Renal pelvic or upper/middle calyceal calculi 
> 2 cm 
1. Endourology (PCNL, flexible URS) 
2. SWL 
3. Laparoscopy 
1 – 2 cm SWL or endourology 
< 1 cm 
1. SWL 
2. Flexible URS 
3. PCNL 
 
Renal lower calyceal calculi 
> 2cm 
1. Endourology 
(PCNL, flexible URS) 
2. SWL 
1 – 2 cm 
Favourable factors for 
SWL 
Yes 
1. SWL 
2. Endourology 
No 
1. Endourology 
2. SWL 
< 1 cm 
1. SWL 
2. Flexible URS 
3. PCNL 
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Recommendation  Grade  
SWL is the first choice for stones < 2 cm within the renal pelvis and 
upper/middle calyces. Larger stones should be treated by PCNL 
B 
For lower calyx, PCNL or flexible URS are recommended even for stones > 1.5 
cm because the efficacy of SWL is limited (depending on 
favourable/unfavourable factors) 
B 
 
 
 
 
 
Ureteric calculi(5) 
 
Table 3: Recommended treatment for ureteric calculi 
Stone size and location First choice Second choice 
Proximal ureter < 10 mm SWL URS 
Proximal ureter > 10 mm URS (retrograde or antegrade) or SWL 
Distal ureter < 10 mm URS or SWL 
Distal ureter > 10 mm URS SWL 
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Recommendation Grade 
Percutaneous antegrade removal of ureteral stones is an alternative when SWL is 
not indicated or has failed and when the upper urinary tract is not amenable to 
retrograde URS 
A 
Patients must be informed about the existing treatment modalities along with 
their risks/benefits 
A 
 
 
 
Contraindications 
 
There are many contraindications for SWL; 
 
• pregnancy, due to the potential disruptive outcome on the foetus  
• bleeding diatheses; correction for at least 24 hours before and 48 hours after treatment  
• untreated urinary tract infections (UTIs) 
• skeletal malformations and severe obesity, which hinder targeting of the stone 
• arterial aneurysm in the vicinity of the treated stone  
• anatomic obstruction distal to the stone(5) 
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Complications 
Table 4: Complications of SWL 
Complications Percentage 
Stone fragment related 
Steinstrasse 4 – 7 
Residual fragment 
regrowth 
21 – 59 
Colic 2 -4 
Infection 
Bacteriuria 7.7 – 23 
Sepsis 1 - 2.7 
Tissue effect 
Renal 
Haematoma, 
symptomatic 
< 1 
Haematoma, 
asymptomatic 
4 – 19 
Cardiovascular 
Dysrhythmia 11 -59 
Morbid cardiac events Case reports 
Gastrointestinal 
Bowel perforation Case reports 
Liver, spleen 
haematoma 
Case reports 
 
Relationship between SWL and diabetes/hypertension is unclear. Published data are 
contradictory and no conclusions can be reached.(5) 
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Anticipated clinical outcome 
A few patients are likely to fail SWL treatment and pretreatment identification of such 
patients avoids needless shock wave exposure. Alternative treatment modalities should be 
employed in these situations. 
 
 Stone burden is one of the most important factors and includes both stone size and 
number. SWL is usually not preferred for stone size > 20mm. 
 Stone position: infundibulopelvic angle and infundibular width/length and calyx 
pelvic height have a bearing on the clearance of lower calyceal calculi. 
 Stone composition: very hard stones like cystine, brushite, calcium oxalate 
monohydrate and very soft stones like matrix calculi have poor fragmentation. 
 Anatomical abnormalities: like horseshoe kidneys, malrotated or duplex systems, 
calyceal diverticulae and post operative strictures have lower clearance rates. 
 Obesity with a body mass index (BMI) of > 25-30.(1,6,7,8) 
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Optimal clinical practise and how to enhance success rate 
 Pre treatment imaging: intravenous urogram (IVU) or non contrast/ contrast enhanced 
CT scan is required for appropriate delineation of the calculus and the collecting 
system. 
 Pre SWL stenting: is only indicated in special situations like single functioning 
kidney, a very large stone bulk or when follow up is likely to be less stringent. This 
may actually reduce clearance rates. 
 Antibiotic prophylaxis: antibiotics are indicated in case of positive culture, suspicion 
of infection stones, history of instrumentation or UTI’s and presence of foreign bodies 
like stents/ nephrostomies. 
 Shock wave rate: rather than a high shock wave frequency of 100-120 per minute, 
lower rates are presently recommended. This leads to better fragmentation and less 
tissue damage. 
 Power ramping: SWL sessions should be stepped up from low to high energy levels 
so as to trigger vasoconstriction and thus causing lesser kidney damage. 
 Mechanical percussion, inversion and diuresis (PID) therapy: is recommended for 
lower calyceal calculi. 
 Adjuvant drug therapy: medical expulsion therapy (MET) using α blockers or calcium 
channel blockers reduces pain and time to stone expulsion as well as brings about 
higher stone free rates.(1,5,9,10,11,12,13,14,15) 
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Role of diuresis 
Diuresis has been proposed as a factor which might enhance both fragmentation and 
clearance of renal and ureteric calculi. Fragmentation is facilitated by a fluid film interface 
between the stone and ureteric wall. Also, the initial shockwaves break the outer shell of the 
calculus and further disintegration of the core is enhanced by the seepage of fluid below the 
cracks, creating an interface. Thus, the effect of the collapsing cavitation bubble is enhanced. 
It is also proposed that diuretics reduce therequirement of total number of shocks and 
sessions.(16,17,18,19) 
 
 
 
 
 
 
 
 
 
 
 
 
18 
 
 
 
 
 
Material and methods  
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Material and methods 
 
Design and location 
This hospital based prospective randomized double blinded placebo controlled trial was 
conducted at the Department of Urology, Christian Medical College, Vellore. 
 
Duration  
Between June 2011 and December 2012. 
 
Patients 
Patients with renal and upper ureteric calculi who satisfied the following inclusion and 
exclusion criteria were included; 
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Inclusion criteria  
Age: adults > 18 years  
Non obstructive radio opaque renal and upper ureteric calculi up to 1.5 cm (obstruction – no 
contrast seen beyond the calculus up to the 1 hour film on intravenous urogram) 
Sterile or treated urine culture 
Normal renal function (creatinine up to 1.4 mg%)  
 
Exclusion criteria  
Anatomical abnormality 
Distal obstruction 
Morbid obesity (body mass index > 40) 
Pregnancy 
Coagulopathy  
History of any previous intervention on the same side 
Significant cardiac history 
 
 
 
 
21 
 
Methodology  
Patients underwent SWL as an out-patient procedure. They were allocated by block 
randomization to either SWL or SWL along with diuretics (placebo or 40 mg furosemide iv 
at the start of SWL). ‘Dornier Compact Delta 2’ electromagnetic lithotripter was used. As per 
protocol they received shocks at a rate of 80/min starting at 7kv with dose escalation up to 
16kv until the stone fragmented or up to a maximum of 1500/2000 shocks per session (for 
renal and upper ureteric calculi respectively) up to a maximum of 3 sessions for stones up to 
1 cm and 4 for stones between 1-1.5cm. Imaging was repeated at 4 days & repeat sessions 
were instituted if required i.e failure of fragmentation, fragments larger than 5mm or lead 
fragment larger than 4mm. 
 
To minimise interindividual variation in fluid intake and eliminate bias, all patients were 
given a target intake value (volume in ml = weight in kg x 50), made to strictly adhere to it 
and followed up with frequency-volume charts.  
 
Data was collected regarding procedure related events like 
Number of shock and sessions required 
Duration of treatment 
Frequency-volume charts to monitor intake-output 
 
 
22 
 
Figure 5: Dornier Compact Delta 2 lithotriptor used at our institution 
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Complications like pain, haematuria, fever, steinstrasse and need for ancillary procedure like 
percutaneous nephrostomy or DJ stenting. 
 
Method of randomization:  
Stratified block randomization was done. The patients were divided into 2 strata;  
Stratum 1: calculi upto 1 cm 
Stratum 2: calculus size from 1.1 to 1.5 cm 
 
In each Stratum, block randomization was done using SAS software with the blocks of 2, 4 
and 6. That is, 25%, 50% and 25% of 2, 4 and 6 blocks was done respectively. This was done 
by the Department of Biostatistics, Christian Medical College, Vellore. 
 
Method of allocation concealment:  
The Department of Biostatistics prepared sealed opaque envelops and sent these to the 
Pharmacy department. 
  
Masking  
The subjects and the investigators were blinded for the allocation. 
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Primary Outcome:  
SWL failure (fragmentation): no fragmentation after 3/4 sessions  
Success rate (clearance): Stone free after 3/4 sessions  
 
For renal calculi, clinically insignificant residual fragments (CIRF) were included as 
successful outcome in calculating the success rate. However, any residual fragments for 
ureteric calculi were considered as a failure for the calculation of success rate. 
 
Secondary Outcome:  
Number of shocks and sessions 
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Target sample size and rationale: 
Based on the review, the clearance rates have been reported to be 70 to 80%. It was assumed 
that the clearance rate would be around 70% in the placebo arm or in the conventional 
treatment. We proposed to suggest diuretics only if there was an improvement of 20% with 
alpha = 5% and power = 80%. The number of subjects, thus needed was 48 in each arm. 
 
Table 5: Sample size calculation 
Two Proportion - Hypothesis Testing - Large Proportion - Equal Allocation 
 
Proportion of clearance in the placebo arm 0.8 0.8 0.8 0.7 0.7 
Proportion of clearance in the Furosemide arm 0.9 0.95 0.95 0.85 0.9 
Estimated risk difference  -0.1 -0.15 -0.15 -0.15 -0.2 
Power (1- beta) % 80 80 70 80 80 
Alpha error (%) 5 5 5 5 5 
1 or 2 sided  2 1 1 1 1 
Required sample size for each arm  199 59 45 95 48 
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Statistical analysis 
Descriptive statistics such as mean, median, standard deviation and range were calculated for each 
study variable. The distribution of study and outcome variables was tabulated according to the 
outcome variable fragmentation and clearance (yes/no). Chi-square test was done to study the 
difference between two proportions and Wilcoxson Mann Whitney two sample test to compare the 
two groups. 
For statistical analysis n-Master version 2 software was used. 
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Results  
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Results  
 
 
During the study period from June 2011 to December 2012, a total of 96 patients were included. 
These comprised both renal and upper ureteric calculi as per inclusion criteria. They were randomised 
into two groups; 
 
 
 
 
Group A: Placebo arm 
Group B: 40 mg Furosemide iv arm 
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Figure 6: CONSORT flow diagram 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total number of patients = 101 
Excluded = 5 
 Did not fit inclusion criteria 
 Missed placebo/Furosemide 
injection 
 Lost to follow up 
Group B: 40 mg Furosemide iv arm 
n = 48 
Group A: Placebo arm 
n = 48 
Total number included in the study 
n = 96 
Renal  calculi = 21 Renal  calculi = 21 Upper ureteric calculi = 27 Upper ureteric calculi = 27 
30 
 
 
 
The mean age in group A was 39.45 years and group B was 38.56 years. 
 
Table 6: Age of patients 
Mean age in years           
           (range) 
Group A Group B 
39.458 (20 – 61) 38.562 (18 – 56) 
 
 
 
 
 
The female to male ratio was almost similar in both groups. There were 30 men and 18 women in 
group A, whereas in group B it was 31 men and 17 women. 
 
Table 7: Sex ratio 
Sex Group A (n = 48) Group B (n = 48) 
Male (percentage) 30 (62.50) 31 (64.58) 
Female (percentage) 18 (37.50) 17 (35.42) 
 
 
 
 
 
 
31 
 
Figure 7: Sex ratio 
 
 
 
 
 
The mean weight of the patients in group A was 61.16 kg and in group B was 61.39 kg. 
 
Table 8: Weight of patients 
Mean weight in  
kilograms (range) 
Group A Group B 
61.166 (35 – 80) 61.395 (42 – 90) 
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The mean calculus size in group A was 9.26 mm and group B was 9.41 mm. 
 
Table 9: Calculus size 
Mean calculus size  
in millimetres (range) 
Group A Group B 
9.260 (4 – 15) 9.416 (5 – 15) 
 
 
 
 
The details were as follows; 
 
Figure 8: Calculus size in group B 
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Figure 9: Calculus size in group B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
2
4
6
8
10
12
14
16
1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47
Size 
in 
mm 
Number of patients 
Group B 
34 
 
The detail of the site of the calculi was as follows; 
 
Table 10: C aculus site 
Site of the 
calculus 
Group A Site of the 
calculus 
Group B 
n % n % 
L LC 4 8.33 L LC 2 4.17 
L P 5 10.42 L MC 2 4.17 
L UC 1 2.08 L P 4 8.33 
L UU 8 16.67 L UC 2 4.17 
R LC 4 8.33 L UU 14 29.17 
R MC 1 2.08 R LC 6 12.50 
R P 4 8.33 R P 4 8.33 
R UC 2 4.17 R UC 1 2.08 
R UU 19 39.58 R UU 13 27.08 
L = left, R = right, LC = lower calyx, P = pelvis, MC = middle calyx, UC = upper calyx, UU = upper 
ureter 
 
This shows that the groups were evenly matched according to the site of calculi as well. 
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Site of the  
calculus 
Group A Group B 
n % n  % 
Lower calyx 8 16.66 8 16.66 
Middle calyx 1 2.08 2 4.16 
Pelvis  9 18.75 8 16.66 
Upper calyx 3 6.25 3 6.25 
Upper ureter 27 56.25 27 56.25 
 
 
 
Figure 10: Calculus site 
 
 
LC = lower calyx, P = pelvis, MC = middle calyx, UC = upper calyx, UU = upper ureter 
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The mean serum creatinine in group A was 1.12 mg% and in group was 1.04 mg%. 
 
Table 11: Serum creatinine 
Mean serum creatinine 
 in mg% (range) 
Group A Group B 
1.122 (0.4 – 1.4) 1.047 (0.75 – 1.4) 
 
 
 
 
 
The mean total number of shocks required for group A was 3849.79 and group B was 3661.46. 
 
Table 12: Number of shocks 
Mean total number of  
shocks (range) 
Group A Group B 
3849.79 (750 – 11000) 3661.46 (1500 – 10000) 
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The details of the number of shocks were as follows; 
 
Total number  
of shocks 
Group A Total number  
of shocks 
Group B 
n % n % 
750 1 2.08 1500 7 14.58 
1500 6 12.50 1600 1 2.08 
2000 14 29.17 1750 1 2.08 
2500 1 2.08 2000 9 18.75 
3000 1 2.08 3000 8 16.67 
3700 1 2.08 3900 1 2.08 
4000 3 6.25 4000 4 8.33 
4500 3 6.25 4500 4 8.33 
5000 2 4.17 6000 12 25.00 
5500 1 2.08 10000 1 2.08 
6000 11 22.92    
7000 2 4.17    
8000 1 2.08    
11000 1 2.08    
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Figure 11: Number of shocks 
 
 
 
 
The mean total number of sessions for group A was 2.25 and group B was 2.12. 
Table 13: Number of sessions 
Mean total number of  
sessions (range) 
Group A Group B 
2.25 (1 – 6) 2.12 (1 – 7) 
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The details of the number of sessions were as follows; 
 
Number of 
sessions 
Group A Number of 
sessions 
Group B 
n % N % 
1 21 43.75 1 18 37.50 
2 6 12.50 2 12 25.00 
3 11 22.92 3 15 31.25 
4 9 18.75 4 2 4.17 
6 1 2.08 7 1 2.08 
 
Figure 12: Number of sessions 
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The fragmentation of calculi in both the groups was as follows; 
Table 14: Fragmentation 
Fragmentation  Group A Group B 
N % n % 
Complete  39 81.25 43 89.58 
Failed  9 18.75 5 10.42 
 
 
 
Figure 13: Fragmentation 
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Figure 14: Fragmented and cleared calculi 
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The clearance of calculi in both the groups was as follows; 
Table 15: Clearance 
Clearance   Group A Group B 
N % n % 
Complete  34 70.83 37 77.08 
Failed  14 29.17 11 22.92 
 
 
 
Figure 15: Clearance 
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The mean duration of treatment in group A was 11.43 days and group B was 11.91 days. 
 
 
Table 16: Duration of treatment 
Mean duration of 
treatment in days  
(range) 
Group A Group B 
11.43 (3 – 30) 11.91 (4 – 45) 
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When the primary outcomes were analysed, it was seen that complete fragmentation was achieved in 
89.58% of the patients in the Furosemide arm as compared to 81.25% in the placebo arm. Clearance 
of the fragments was achieved in 77.08% of the patients in the Furosemide arm as compared to 
70.83% in the placebo arm. On analysis, there was no statistically significant difference between the 
groups for both fragmentation and clearance, though the rates were higher in the Furosemide arm. 
 
 
Table 17: Statistical analysis of fragmentation and clearance of calculi 
Fragmentation  Group A Group B Effect  
size 
95% C I p value 
n % n % % 
(-22.35, 
 5.69) 
0.25 
Complete  39 81.25 43 89.58 
-8.33 Failed  9 18.75 5 10.42 
Total  48 100.00 48 100.00 
 
Clearance   Group A Group B Effect  
size 
95% C I p value 
n % n % % 
(-23.76, 
 11.26) 
0.49 
Complete  34 70.83 37 77.08 
-6.25 
 
Failed  14 29.17 11 22.92 
Total  48 100.00 48 100.00 
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Similarly, the difference in the total number of shocks required, which was a secondary outcome, was 
not statistically significant between the two groups, though the mean total number of shocks required 
was higher in the placebo arm. 
 
 
Table 18: Statistical analysis of number of shocks 
Total number 
 of shocks 
Group A p value* 
Mean SD Median Q1 Q3 
0.68 
3894.79 2254.41 3850 2000 6000 
Group b 
Mean SD Median Q1 Q3 
3661.46 1946.53 3000 2000 6000 
* Non Parametric Wilcoxon two sample test 
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When the total number of sessions required were analysed, it was seen that a higher number of 
patients required ≥ 3 sessions in the placebo arm as compared to the Furosemide arm. 
 
 
Table 19: Number of sessions 
Number of 
sessions 
Group A Number of 
sessions 
Group B 
n % n % 
1 21 43.75 1 18 37.50 
2 6 12.50 2 12 25.00 
3 11 22.92 3 15 31.25 
4 9 18.75 4 2 4.17 
6 1 2.08 7 1 2.08 
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Discussion  
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Discussion  
 
SWL has established itself as a frontline treatment modality for renal and ureteric calculi, since its 
inception in the early 1980’s. However, the constant rise in technology and the challenge offered by 
newer techniques like URS, PCNL and RIRS highlights the need to evolve novel strategies to 
improve treatment outcomes and thus, continue to play an important role as a treatment option. 
 
Various attempts have been made in the past to enhance the effectiveness of SWL, which have 
become a part of the standard treatment protocol today. These include lower shock wave rate, power 
ramping, percussion, inversion and diuresis (PID) for lower calyceal calculi and medical expulsion 
therapy (MET) using α-blockers. 
 
This study aimed at assessing the effect of diuretics on SWL. Set in the Christian Medical College 
Vellore, a tertiary care teaching hospital in Tamil Nadu, we analysed a group of patients with renal 
and upper ureteric calculi who underwent SWL treatment for the same and the effect of diuretics 
(placebo versus 40 mg furosemide iv) on stone fragmentation and clearance. 
 
We found that, though the fragmentation of calculi was higher in the Furosemide arm as compared to 
placebo arm, it was not statistically significant. Similarly, there was no statistical difference detected 
in the clearance of the fragments. 
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The total number of shocks and sessions required was lesser in the Furosemide arm in comparison to 
the placebo arm, though this too did not reach statistical significance. 
 
Our study was in concordance with the study by Azm TA et al who reported an overall fragmentation 
rate of 87% for ureteric calculi in the control group versus 96.2% in the furosemide arm. Stone 
clearance rates were reported as 87% versus 92.3% respectively. However, when further analysed 
according to the site of the calculus, the two groups were comparable for upper and mid ureteric 
calculi. Significant difference was achieved between the two groups only for the distal ureteric calculi 
(93.8% versus 70.6% for fragmentation and 87.5% versus 70.6% for clearance in the furosemide and 
control groups respectively). Lower number of shocks and sessions were required in the Furosemide 
group (5300 versus 6295 average shocks and 1.5 versus 1.92 average number of sessions for 
Furosemide versus control group respectively). 
 
Zomorrodi A et al reported a much higher difference in both stone fragmentation and clearance for 
ureteric calculi using 40 mg Furosemide before the start of SWL. Fragmentation was achieved in 
93.1% versus 81% in the Furosemide and control groups respectively. Clearance was reported as 
88.4% versus 68.2% for the above groups. 
 
For lower calyceal calculi Tahir MM et al reported a clearance rate of 73.3% using 20 mg 
Furosemide versus 60% in the control arm. 
 
 
Though the results of our study were similar to those reported in the literature, the differences 
achieved in the placebo versus Furosemide arm were not high enough to achieve statistical 
significance. However, this is the first randomised double blinded placebo controlled trial to 
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demonstrate higher, though marginal fragmentation and clearance rates in addition to the requirement 
of a lower mean number of shocks and sessions for SWL using diuretics. 
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Conclusions  
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Conclusions  
 
The use of diuretics along with SWL treatment of renal and upper ureteric calculi results in higher 
fragmentation and clearance rates along with a requirement of lower number of shocks and sessions, 
though not statistically significant. 
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UROLOGY
S no H no name age sex weight fluid req cal site cal size
2 187957f dipak sen 45 m 67 3350 R MC 8
5 197482f narayan 35 m 60 3000 R P 6
6 180601b devaraj 55 m 75 3750 R LC 8
9 253941f kiran prasad 40 m 65 3250 R UC 5
10 688375d rivervulet 36 f 72 3600 L LC 6
12 027993d jamuna devi 50 f 56 2800 L LC 9
13 022828f dilip kumar 56 m 70 3500 L UC 10
14 268628f khuku rani 30 f 56 2800 L P 7
17 301155f subashish 38 m 75 3750 R LC 10
20 324528f nitu mani 31 m 54 2700 L LC 7
21 325125f saraswathi 31 f 35 1750 R LC 5
26 824521b ratna kishore 30 m 65 3250 L LC 7
29 161376f nagaraj 35 m 62 3100 R LC 10
3 704083a archana 27 f 49 2450 R P 15
4 573002d elamathi 22 f 60 3000 R P 15
5 500468d saraswathi 42 f 74 3700 R P 14
8 317815f sunil ram 26 m 54 2700 L P 13
11 343536f john 32 m 73 3650 L P 13
12 345378f chandana 42 f 60 3000 L P 13
14 339504f rekha 39 f 50 2500 R UC 12
17 721339d tirumalai 61 m 72 3600 L P 13
1 953313d subir mandal 36 m 67 3350 L UU 9.5
2 962974d ranganathan 45 m 56 2800 R UU 6
5 763709c narayan ghosh 51 m 56 2800 R UU 7
7 045791f rahima bee 60 f 56 2800 L UU 6
8 806744c chawngthan 52 m 55 2750 L UU 9
11 113542f manoj 34 m 59 2950 R UU 10
14 151921f jayanthi 47 f 76 3800 R UU 8
15 167788f ammu v 24 f 57 2850 L UU 8
18 254027d arumugam 46 m 64 3200 R UU 8
20 205683f kanak lata 47 f 50 2500 L UU 8
22 229648f suresh babu 47 m 73 3650 R UU 4
23 509214d dilip 45 m 60 3000 R UU 7
26 842635c sakthivelu 34 m 66 3300 R UU 9
28 282139f varghese 49 m 65 3250 R UU 8
29 097944d ravisankar 50 m 80 4000 R UU 9
32 287130f vijayakumari 21 f 39 1950 L UU 7
35 329803c chapla 34 f 60 3000 R UU 6
36 535777d kamala 49 f 60 3000 R UU 6
39 326561f rajak ali 30 m 52 3100 L UU 5
40 370992f sourav singh 28 m 60 3000 R UU 6
2 977485d nirmala 50 f 60 3000 R UU 13
5 100052f manoj kumar 26 m 50 2500 R UU 12
7 160736f leeza pradhan 20 f 54 2700 R UU 11
8 155090f subal chandra 43 m 65 2150 R UU 14
11 097944d ravisankar 50 m 70 3500 R UU 13
14 326217f sarbeshwar 29 m 60 3000 L UU 14
15 339039f daniel 44 m 62 3100 R UU 15
1 195809f kabir uddin 28 m 65 3250 R LC 5
3 214339f mukti 28 f 52 2600 L P 9
4 225691f sanjay 33 m 60 3000 R LC 9
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7 866790d gomathi 21 f 43 2150 L LC 6
8 315664d poonam 27 f 43 2150 L P 9
11 729429a janardhan 51 m 61 3050 R LC 5
15 251465f krishna 50 f 75 3750 R P 9
16 489873c chandra 54 f 50 2500 R LC 7
18 288307f parboti 50 f 49 2450 R LC 10
19 907358c valarmathi 44 f 54 2700 R LC 6
22 290383f lakshmi prasad 32 f 50 2500 L MC 5
24 345804f paulraj 52 m 70 3500 L UC 9
27 954438c rajkumar 27 m 75 3750 L UC 5
28 329803c chapala 34 f 60 3000 L MC 6
2 224357f basu sen 40 m 48 2400 R P 12
6 681403d abhishek 18 m 75 3750 R P 15
7 258967f rina chanda 47 f 42 2100 L LC 12
9 292199f sudhakar 45 m 70 3500 L P 15
10 341214f sakawan 34 f 75 3750 R UC 15
13 353800f ramprasad 34 m 62 3100 R P 15
16 940808d suguna 52 f 55 2750 L P 15
3 968044d jayachandra 47 m 90 4500 L UU 7
4 028558f balaji m 30 m 85 4250 R UU 6
6 030903f abraham 55 m 76 3800 R UU 7
9 057830f venkatesan 27 m 56 2800 R UU 8
10 083563f tahera 33 f 70 3500 R UU 7
12 896421d ragothaman 56 m 60 3000 R UU 9
13 104475f nand kishore 46 m 69 3450 L UU 9
16 170188f paneer selvam 31 m 76 3550 L UU 8
17 575447a raman 54 m 60 3000 R UU 10
19 913298C ILLAYARAJA 30 m 55 2750 L UU 7
21 223352f gautam 27 m 61 3050 L UU 8
24 249454f jaydeep 50 m 70 3500 L UU 8
25 087605f anusuya 46 m 50 2500 L UU 10
27 272689f mojaffar 25 m 53 2650 L UU 10
30 178108c dinesh kumar 56 m 65 3250 L UU 10
31 308064f sourav ghosh 23 m 44 2200 L UU 6
33 332278f partha dey 34 m 62 3100 R UU 8
34 303951f govinda 25 m 50 2500 R UU 6
37 369085d swapan 43 m 63 3150 R UU 10
38 345585f sanatan 48 m 62 3100 R UU 10
1 392570d dakshna moort 35 m 67 3350 L UU 11
3 729112d manik das 41 m 73 3650 L UU 11
6 117784f sarita pradha 35 f 66 3300 L UU 15
9 174888f tili kumari 35 f 45 2750 R UU 12
10 986242b jeslet 36 f 65 3250 L UU 15
12 290975f dayarani 42 f 59 2950 R UU 12
13 264866f jagannath 40 m 61 3050 R UU 13
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creat urine cs shocks sessions fragmentationclearance FV chart durnduration Stratum
1.2 conta 6000 4 Complete Complete 3200/2450 11 1
1.33 ng 1500 1 Complete Complete 2000/1100 14 1
1.32 Klebsiella 1500 1 Complete Complete 3400/2300 5 1
1.32 ng 3000 2 Failed Failed 2950/2100 10 1
1.1 conta 1500 1 Complete Complete 3250/2500 16 1
1.34 conta 6000 4 Complete Failed 3000/2500 20 1
1.29 conta 6000 4 Failed Failed 3300/2000 14 1
0.89 conta 6000 4 Failed Failed 3000/2050 16 1
1.25 Ecoli 500 5000 3 Complete Complete 3600/2500 14 1
1.26 conta 1500 1 Complete Complete 3000/2750 7 1
0.83 conta 1500 1 Complete Complete 2000/1100 6 1
1.07 ng 7000 4 Complete Complete 3400/2150 30 1
1.07 ng 4500 3 Failed Failed 3000/1700 15 1
1.18 conta 4500 3 Complete Complete 1750/1200 7 2
1.08 conta 7000 4 Complete Complete 2500/1950 30 2
0.84 conta 1500 1 Complete Complete 4000/2100 1 2
1.03 ng 6000 4 Complete Complete 2575/2430 29 2
1.37 ng 4500 3 Complete Failed 3950/3000 10 2
1.08 conta 5000 3 Complete Complete 3500/2100 14 2
1.13 ng 11000 6 Failed Failed 2100/1700 20 2
1.4 ng 6000 4 Failed Failed 3000/1900 14 2
1 ng 3700 2 Complete Complete 3500/2000 7 1
1.4 NG 2000 1 Complete Complete 3000/1750 9 1
1.1 ng 2500 2 Complete Complete 2900/2150 10 1
0.9 4500 Ecoli 2000 1 Complete Complete 3000/1700 5 1
0.9 conta 6000 3 Complete Failed 2700/2850 11 1
1.03 conta 5500 3 Complete Complete 3100/2400 9 1
0.93 conta 6000 3 Complete Failed 3200/2100 19 1
0.93 conta 2000 1 Complete Complete 2250/1150 1 1
1.4 ng 6000 3 Complete Complete 2800/1500 18 1
0.87 conta 6000 3 Complete Complete 2450/1500 5 1
1.24 NG 2000 1 Complete Complete 2750/1350 6 1
1.38 NG 2000 1 Complete Complete 2950/2000 5 1
1.28 ng 2000 1 Complete Complete 3300/1850 7 1
1.2 ng 6000 3 Failed Failed 3250/2100 15 1
1.37 ng 2000 1 Complete Complete 3400/2400 1 1
0.92 conta 4000 2 Complete Complete 2000/1150 10 1
0.81 conta 2000 1 Complete Failed 3000/1750 4 1
1.03 conta 2000 1 Complete Complete 3500/2300 5 1
1.27 conta 2000 1 Complete Complete 2600/1750 6 1
0.4 e.co.i 21000 4000 2 Complete Complete 2600/1900 10 1
1.2 ng 4000 2 Failed Failed 2850/1900 7 2
1.3 conta 2000 1 Complete Complete 2700/1950 8 2
0.91 conta 750 1 Complete Complete 2400/2000 6 2
1.05 ng 2000 1 Complete Complete 1900/1600 12 2
1.37 ng 2000 1 Complete Complete 3400/2400 14 2
1.06 conta 2000 1 Complete Complete 3250/2650 6 2
1.23 600 kleb 8000 4 Failed Failed 3500/2600 30 2
1.1 conta 3000 2 Complete Complete 3550/2650 5 1
0.8 conta 3000 2 Complete Complete 2850/1100 13 1
1.04 ng 1500 1 Complete Complete 4000/1700 8 1
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1.06 conta 1500 1 Complete Complete 1800/2000 10 1
0.79 conta 1500 1 Complete Complete 1800/1250 6 1
1.04 Ecoli 4000 4500 3 Complete Complete 2650/1850 14 1
0.84 conta 6000 3 Failed Failed 3000/2250 7 1
0.87 conta 1500 1 Complete Complete 2150/1500 14 1
1.01 ng 4500 3 Complete Complete 2200/1650 13 1
0.9 strept 50000 3000 2 Complete Complete 2600/2000 10 1
0.84 NG 6000 4 Complete Complete 2500/1800 12 1
1.1 conta 3000 2 Complete Complete 3000/2100 14 1
0.98 conta 1500 1 Complete Complete 3100/1200 4 1
0.81 conta 3000 2 Complete Complete 2950/1900 11 1
1.29 conta 3000 2 Complete Complete 3000/1900 9 2
1.12 conta 3000 2 Complete Complete 3500/1800 5 2
0.85 conta 6000 4 Complete Complete 1800/1100 18 2
1.09 conta 10000 7 Failed Failed 3200/2700 45 2
1.06 E.coli 10000 3000 2 Complete Failed 3700/2150 17 2
1.05 conta 3900 3 Complete Complete 3500/2700 18 2
0.87 conta 4500 3 Failed Failed 3000/2100 18 2
1.2 1800 ecoli 2000 1 Complete Complete 4000/3100 5 1
1.4 conta 2000 1 Complete Failed 3850/1850 10 1
0.9 conta 2000 2 Complete Complete 3800/2400 7 1
0.9 ng 4000 1 Complete Complete 2350/1500 12 1
0.9 conta 4000 2 Complete Failed 3400/1725 14 1
1.19 conta 6000 3 Complete Failed 3400/2750 21 1
0.9 ng 2000 1 Complete Complete 3650/2890 5 1
1.27 ng 1500 1 Complete Complete 3250/2100 10 1
1.09 conta 6000 3 Complete Complete 3200/2850 31 1
1.04 Mixture 6000 3 Complete Complete 2500/1300 18 1
1.26 ng 1750 1 Complete Complete 2000/1875 6 1
1.26 conta 1500 1 Complete Complete 3300/1050 11 1
1.02 conta 2000 1 Complete Complete 1900/1100 7 1
1.1 conta 2000 1 Complete Complete 2600/2000 4 1
1.2 conta 6000 3 Failed Failed 3100/2000 14 1
1.03 conta 2000 1 Complete Complete 3000/2800 6 1
1.06 conta 6000 3 Complete Complete 3100/1900 18 1
1.09 conta 6000 3 Complete Complete 2000/1650 14 1
1.2 ng 6000 3 Failed Failed 3250/2400 10 1
1.26 conta 6000 3 Complete Failed 3200/2100 14 1
1.3 conta 1600 1 Complete Complete 3500/1350 6 2
1.2 conta 2000 1 Complete Complete 3650/3000 8 2
0.75 enterococcus 4000 2 Complete Complete 3300/1450 8 2
1.06 insig 4500 3 Complete Complete 2800/2100 15 2
1.13 proteus 2000 1 Complete Complete 3300/1200 10 2
0.8 conta 4000 2 Complete Failed 2500/1500 7 2
1.25 ng 6000 3 Complete Complete 2900/2000 10 2
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